Dnase1l3-deficient mice, a model of pediatric-onset SLE, showed the early presence of anti-dsDNA and anti-chromatin antibodies, suggesting that Dnase1L3 might function as a key modulator following NLRP3 inflammasome activation (70). This evidence concerns the gene NLRP3 and systemic lupus erythematosus.